#USA #New York #Securities Fraud #Pomerantz LLP #Lantheus Holdings

Pomerantz Law Firm's Recent Action

On October 18, 2025, Pomerantz LLP, a prominent firm specializing in securities class actions, announced the initiation of a class action lawsuit against Lantheus Holdings, Inc. (NASDAQ: LNTH). This legal action is aimed at addressing the financial losses incurred by investors due to potential securities fraud or other unlawful business practices involving the company and its executives.

Nature of the Class Action

Investors of Lantheus Holdings are urged to take action by contacting the law firm, especially those who purchased shares during a specific class period. The filing indicates that the investors may have grounds for a lawsuit due to either misleading information or unsatisfactory disclosures made by the company officials.

Those interested in participating in the class action have until November 10, 2025, to notify the court of their intent to be appointed as Lead Plaintiff. Interested parties can reach out to Pomerantz LLP through the provided email address and are encouraged to include necessary identification details.

The Financial Context

This class action comes on the heels of disappointing earnings reports from Lantheus Holdings. On May 7, 2025, the company reported its financial results for the first quarter, which underperformed relative to market expectations. One major factor cited was a notable decline in sales of their radiopharmaceutical oncology product, Pylarify. The company attributed this downturn to a so-called "temporal competitive disruption," which severely impacted its revenue forecast, culminating in a massive drop in stock price—$24.35 per share, equivalent to a 23.23% decline—on the same day.

Lantheus continued to face challenges, reporting similarly disappointing results in the second quarter of 2025. On August 6, the firm disclosed that its earnings-per-share and revenue failed to meet expectations once again, revealing a downturn of 8.3% in sales year-over-year for Pylarify and prompting further reductions in their previous growth forecasts. Consequently, the share price witnessed a sharp decline of $20.76, or 28.58%, closing at $51.87.

Such fluctuations have left investors questioning Lantheus Holdings’ business practices and adherence to securities laws, laying the groundwork for the current class action.

Pomerantz LLP's Commitment to Investors

Pomerantz LLP has a long history of advocating for investor rights, focusing on representing victims of securities fraud. The firm is recognized as a leader in conducting class action litigation, having recouped significant financial damages for its clients over more than 85 years of operation. Founded by Abraham L. Pomerantz, often hailed as the dean of the class action bar, Pomerantz continues to advance its mission of fighting corporate misconduct and protecting shareholders' interests.

With offices in major cities including New York, Chicago, and Los Angeles, Pomerantz is well-equipped to handle complex securities litigation. Their recent actions against Lantheus Holdings reinforce their commitment to addressing corporate accountability and providing a strong voice for investors who may have been misled.

Conclusion

Investors who believe they have been affected by Lantheus Holdings' actions are encouraged to reach out to Pomerantz LLP as soon as possible. By doing so, they can ensure their voices are heard and their rights are pursued in the ongoing legal landscape surrounding this case. Details regarding the lawsuit and contact information can be found on Pomerantz’s official website.